The main purpose of this study is to compare the cartilage volume loss of the lateral compartment (femoral condyle and tibial plateau) at the Baseline visit and after 24 months of treatment in patients treated with CHONDROITIN SULPHATE (CONDROSAN) 1200 mg daily vs. patients treated with CELECOXIB 200 mg daily.
Read more: http://www.clinicaltrials.gov/ct2/show/NCT01354145?cond=%22Arthritis%22&lup_s=07/28/2011&lup_d=30
